article thumbnail

Bluebird's next gene therapy gets backing from European regulator

Bio Pharma Dive

The treatment, for a progressive, often deadly brain disease, could soon become Bluebird's third approved product and one of only a handful of marketed gene therapies in the world.

article thumbnail

The drug industry continues to dare regulation

World of DTC Marketing

Reportedly, the cost of production for molnupiravir stands at about $17.74. The post The drug industry continues to dare regulation appeared first on World of DTC Marketing.com. Pfizer’s Paxlovid currently costs about $530 for a five-day course of the treatment. Merck’s molnupiravir, now approved for use in the U.K.,

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How Common Is Salmonella in Chicken? New USDA Regulations Target Frozen Products

XTalks

To combat food poisoning, US agriculture officials introduced a final rule last Friday, mandating significant reductions in Salmonella bacteria in specific chicken products. Starting in 2025, high levels of Salmonella in frozen breaded and stuffed chicken products will classify them as adulterated. How Common Is Salmonella in Chicken?

article thumbnail

Cabinet approves signing of MoUs between India and Suriname in the field of medical products regulation

AuroBlog - Aurous Healthcare Clinical Trials blog

An MoU […]

article thumbnail

FDA unveils comprehensive strategy for regulating AI in medical products

BioPharma Reporter

With the pharma and healthcare landscape increasingly being shaped by artificial intelligence (AI), the US Food and Drug Administration (FDA) has taken proactive steps to outline a comprehensive strategy for regulating AI in medical products.

article thumbnail

Bluebird says gene therapy 'very unlikely' cause of cancer case in trial

Bio Pharma Dive

and European regulators in hopes of resuming study of the treatment as well as sales of a related product. The biotech is discussing its findings with U.S.

article thumbnail

States look to regulate weed alternatives like delta-8 as sales explode

NPR Health - Shots

Delta-8 is a hemp product designed to get users high, but misleading labels or added chemicals have caused people to get sick. And a lack of federal regulation or guidance has states stepping in.